Biomonitoring of a population of Portuguese workers exposed to lead

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 721, Issue 1, 2011, Pages 81-88

  García Lestón, Julia ^a   Roma Torres, Joana ^b,c   Vilares, Maria ^d   Pinto, Rui ^e   Cunha, Luís M ^f   Prista, João ^c   Teixeira, Joao Paulo ^b   Mayan, Olga ^b   Pásaro, Eduardo ^a   Méndez, Josefina ^a   Laffon, Blanca ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b NATIONAL INSTITUTE OF HEALTH   (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^d NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^e UNIVERSITY OF LISBON   (Portugal)

^f UNIVERSITY OF PORTO   (Portugal)

Author keywords

Aminolevulinic acid dehydratase; Comet assay; Lead; Lymphocyte subsets; T cell receptor mutation assay; Vitamin D receptor

Indexed keywords

CD19 ANTIGEN; HEMOGLOBIN; LEAD; PORPHOBILINOGEN SYNTHASE; PROTOPORPHYRIN ZINC; T LYMPHOCYTE RECEPTOR; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ASSESSMENT; COMET ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GENOTOXICITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOTOXICITY; INDUSTRIAL WORKER; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NONHUMAN; OCCUPATIONAL EXPOSURE; PORTUGAL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; COMET ASSAY; HUMANS; IMMUNITY; LEAD; LYMPHOCYTE SUBSETS; MALE; MUTAGENS; OCCUPATIONAL EXPOSURE; PORTUGAL;

EID: 79951682693     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2011.01.001     Document Type: Article

References (56)

1. Thornton I., Rautiu R., Brush S. Lead The Facts 2001, IC Consultants Ltd., London, UK.
2. Lovei M. Phasing out lead from gasoline: worldwide experience and policy implications, Pollution Management Series 1997, World Bank technical paper No. 397.
3. Nordic Council of Ministers, Lead Review, 2003, available in , last consulted August 12, 2010. http://www.who.int/ifcs/documents/forums/forum5/nmr_lead.pdf.
4. ILZSG (International Lead and Zinc Study Group), Lead and Zinc Statistics, 2007, available in , last consulted February 4, 2010. http://www.ilzsg.org/.
5. Roberts H. Changing patterns in global lead supply and demand. J. Power Sources 2003, 116:23-31.
6. ATSDR (Agency for Toxic Substances and Disease Registry) Toxicological Profile for Lead, vol. 662 2007, Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA.
7. Johnson F.M. The genetic effects of environmental lead. Mutat. Res. 1998, 410:123-140.
8. García-Lestón J., Méndez J., Pásaro E., Laffon B. Genotoxic effects of lead: an updated review. Environ. Int. 2010, 36:623-636.
9. IARC (International Agency for Research on Cancer) Inorganic and organic lead compounds. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 87 2006, IARC, Lyon.
10. Trust K.A., Miller M.W., Ringelman J.K., Orme I.M. Effects of ingested lead on antibody production in mallards (Anas platyrhynchos). J. Wildl. Dis. 1990, 26:316-322.
11. McCabe M.J., Singh K.P., Reiners J.J. Low level lead exposure in vitro stimulates the proliferation and expansion of alloantigen-reactive CD4 (high) T cells. Toxicol. Appl. Pharmacol. 2001, 177:219-231.
12. Mishra K.P. Lead exposure and its impact on immune system: a review. Toxicol. In Vitro 2009, 23:969-972.
13. Parsons P.J., Reilly A.A., Esernio-Jenssen D., Werk L.N., Mofenson H.C., Stanton N.V., Matte T.D. Evaluation of blood lead proficiency testing: comparison of open and blind paradigms. Clin. Chem. 2001, 47:322-330.
14. Prista J., Pinto R., Aguiar P. Determination of zinc protoporphyrin with a portable hematofluorimeter: research on data validity. Revista Portuguesa de Saúde Pública 2002, 20:5-10. (in Portuguese).
15. Berlin A., Schaller K.H. European standardized method for the determination of delta-aminolevulinic acid dehydratase activity in blood. Z. Klin. Chem. Klin. Biochem. 1974, 12:389-390.
16. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
17. Laffon B., Pasaro E., Mendez J. DNA damage and repair in human leukocytes exposed to styrene-7,8-oxide measured by the comet assay. Toxicol. Lett. 2002, 126:61-68.
18. Cebulska-Wasilewska A. Response to challenging dose of X-rays as a predictive assay for molecular epidemiology. Mutat. Res. 2003, 544:289-297.
19. Akiyama M., Kyoizumi S., Hirai Y., Kusunoki Y., Iwamoto K.S., Nakamura N. Mutation frequency in human blood cells increases with age. Mutat. Res. 1995, 338:141-149.
20. Suzen H.S., Duydu Y., Aydin A., Isimer A., Vural N. Influence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism on biomarkers of lead exposure in Turkish storage battery manufacturing workers. Am. J. Ind. Med. 2003, 43:165-171.
21. Schwartz B.S., Stewart W.F., Kelsey K.T., Simon D., Park S., Links J.M., Todd A.C. Associations of tibial lead levels with Bsm I polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ. Health Perspect. 2000, 108:199-203.
22. Cooper G.S., Umbach D.M. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J. Bone Miner. Res. 1996, 11:1841-1849.
23. Amorim A., Rocha J., Santos M.T. Distribution of ACP1, AK1 and ALAD polymorphisms in northern Portugal. Gene Geogr. 1994, 8:147-150.
24. Caeiro B., Rey D. Genetic heterogeneity of delta-aminolevulinate dehydrase and phosphoglycolate phosphatase in north-west Spain. Hum. Hered. 1985, 35:21-24.
25. Ahamed M., Verma S., Kumar A., Siddiqui M.K.J. Blood lead levels in children of Lucknow, India. Environ. Toxicol. 2009, 25:48-54.
26. Grover P., Rekhadevi P.V., Danadevi K., Vuyyuri S.B., Mahboob M., Rahman M.F. Genotoxicity evaluation in workers occupationally exposed to lead. Int. J. Hyg. Environ. Health 2010, 213:99-106.
27. Schwartz B.S., Hu H. Adult lead exposure: time for change. Environ. Health Perspect. 2007, 115:451-454.
28. Landrigan P.J., Silbergeld E.K., Froines J.R., Pfeffer R.M. Lead in the modern workplace. Am. J. Public Health 1990, 80:907-908.
29. Silbergeld E., Landrigan P.J., Foines J.F., Pfeffer R.M. The occupational lead standard: a goal unachieved, a process in need of repair. New Solut. 1991, (Spring):20-30.
30. Lee S.S., Lee B.K., Lee G.S., Stewart W.F., Simon D., Kelsey K., Todd A.C., Schwartz B.S. Associations of lead biomarkers and delta-aminolevulinic acid dehydratase and vitamin D receptor genotypes with hematopoietic outcomes in Korean lead workers. Scand. J. Work Environ. Health 2001, 27:402-411.
31. Kasuba V., Rozgaj R., Milic M., Zeljezic D., Kopjar N., Pizent A., Kljakovic-Gaspic Z. Evaluation of lead exposure in battery-manufacturing workers with focus on different biomarkers. J. Appl. Toxicol. 2009, 30:321-328.
32. Wang Q., Zhao H.H., Chen J.W., Hao Q.L., Gu K.D., Zhu Y.X., Zhou Y.K., Ye L.X. delta-Aminolevulinic acid dehydratase activity, urinary delta-aminolevulinic acid concentration and zinc protoporphyrin level among people with low level of lead exposure. Int. J. Hyg. Environ. Health 2009, 213:52-58.
33. Warren M.J., Cooper J.B., Wood S.P., Shoolingin-Jordan P.M. Lead poisoning, haem synthesis and 5-aminolaevulinic acid dehydratase. Trends Biochem. Sci. 1998, 23:217-221.
34. Sakai T., Morita Y. delta-Aminolevulinic acid in plasma or whole blood as a sensitive indicator of lead effects, and its relation to the other heme-related parameters. Int. Arch. Occup. Environ. Health 1996, 68:126-132.
35. Sakai T. Biomarkers of lead exposure. Ind. Health 2000, 38:127-142.
36. Schwartz B.S., McGrail M.P., Stewart W., Pluth T. Comparison of measures of lead exposure, dose, and chelatable lead burden after provocative chelation in organolead workers. Occup. Environ. Med. 1994, 51:669-673.
37. Apostoli P., Baj A., Bavazzano P., Ganzi A., Neri G., Ronchi A., Soleo L., Di L.L., Spinelli P., Valente T., Minoia C. Blood lead reference values: the results of an Italian polycentric study. Sci. Total Environ. 2002, 287:1-11.
38. Bárány E., Bergdahl I.A., Bratteby L.E., Lundh T., Samuelson G., Schutz A., Skerfving S., Oskarsson A. Trace elements in blood and serum of Swedish adolescents: relation to gender, age, residential area, and socioeconomic status. Environ. Res. 2002, 89:72-84.
39. Stoleski S., Karadzinska-Bislimovska J., Stikova E., Risteska-Kuc S., Mijakoski D., Minov J. Adverse effects in workers exposed to inorganic lead. Arh. Hig. Rada. Toksikol. 2008, 59:19-29.
40. Prista J., Uva A.S. Biological monitoring of lead-exposed workers: comparison among some effect markers (in Portuguese). Revista Saúde & Trabalho 2005, 5:37-57.
41. Froom P., Kristal-Boneh E., Benbassat J., Ashkanazi R., Ribak J. Lead exposure in battery-factory workers is not associated with anemia. J. Occup. Environ. Med. 1999, 41:120-123.
42. Collins A.R. The comet assay for DNA damage and repair. Mol. Biotechnol. 2004, 26:249-261.
43. Chen Z., Lou J., Chen S., Zheng W., Wu W., Jin L., Deng H., He J. Evaluating the genotoxic effects of workers exposed to lead using micronucleus assay, comet assay and TCR gene mutation test. Toxicology 2006, 223:219-226.
44. Ishioka N, Umeki S., Hirai Y., Akiyama M., Kodama T., Ohama K., Kyoizumi S. Stimulated rapid expression in vitro for early detection of in vivo T-cell receptor mutations induced by radiation exposure. Mutat. Res. 1997, 390:269-282.
45. Maluf S.W., Erdtmann B. Follow-up study of the genetic damage in lymphocytes of pharmacists and nurses handling antineoplastic drugs evaluated by cytokinesis-block micronuclei analysis and single cell gel electrophoresis. Mutat. Res. 2000, 471:21-27.
46. Garaj-Vrhovac V., Kopjar N. Investigation into possible DNA damaging effects of ultrasound in occupationally exposed medical personnel-the alkaline comet assay study. J. Appl. Toxicol. 2005, 25:184-192.
47. Ündeger Ü., Basaran N., Canpinar H., Kansu E. Immune alterations in lead-exposed workers. Toxicology 1996, 109:167-172.
48. Basaran N., Ündeger Ü. Effects of lead on immune parameters in occupationally exposed workers. Am. J. Ind. Med. 2000, 38:349-354.
49. Kuo H.W., Hsiao T.Y., Lai J.S. Immunological effects of long-term lead exposure among Taiwanese workers. Arch. Toxicol. 2001, 75:569-573.
50. Taiwan IOSH (Institute of Occupational Safety and Health), The preliminary study on the effects of exposure of heavy metals on immune function of labors. IOSH85-M362, Taiwan (ROC), 1996.
51. Fischbein A., Tsang P., Luo J.-C.J., Roboz J.P., Jiang J.D., Bekesi J.G. Phenotypic aberrations of CD3+ and CD4+ cells and functional impairments of lymphocytes at low-level occupational exposure to lead. Clin. Immunol. Immunopathol. 1993, 66:163-168.
52. Pinkerton L.E., Biagini R.E., Ward E.M., Hull R.D., Deddens J.A., Boeniger M.F., Schnorr T.M., Mackenzie B.A., Luster M.I. Immunologic findings among lead-exposed workers. Am. J. Ind. Med. 1998, 33:400-408.
53. Mishra K.P., Rani R., Yadav V.S., Naik S. Effect of lead exposure on lymphocyte subsets and activation markers. Immunopharmacol. Immunotoxicol. 2010, 32:446-449.
54. CDC (Center for Disease Control), The health benefits of smoking cessation. A report of the Surgeon General. US Department of Health and Human Services, Atlanta, 1990.
55. Carlberg C., Seuter S. A genomic perspective on vitamin D signaling. Anticancer Res. 2009, 29:3485-3493.
56. Schwartz B.S., Lee B.-K., Lee G.-S., Stewart W.F., Simon D.J., Kelsey K., Todd A.C. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ. Health Perspect. 2000, 108:949-954.